Kinaxis Inc (TSE:KXS) had its price objective increased by Laurentian Bank of Canada from C$70.00 to C$75.00 in a research report sent to investors on Monday morning.

Other analysts have also issued research reports about the company. Laurentian boosted their price target on Kinaxis from C$70.00 to C$75.00 in a research note on Monday. RBC Capital Markets boosted their price target on Kinaxis from C$68.00 to C$72.00 in a research note on Saturday, August 6th. CIBC boosted their price target on Kinaxis from C$52.00 to C$75.00 in a research note on Saturday, August 6th. Canaccord Genuity boosted their price target on Kinaxis from C$52.00 to C$70.00 and gave the company a buy rating in a research note on Saturday, August 6th. Finally, BMO Capital Markets reaffirmed an outperform rating and issued a C$74.00 price target on shares of Kinaxis in a research note on Monday. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus target price of C$68.73.

Analyst Recommendations for Kinaxis (TSE:KXS)

Kinaxis (TSE:KXS) opened at 65.42 on Monday. The company’s 50-day moving average price is $63.88 and its 200 day moving average price is $54.43. Kinaxis has a 52 week low of $32.60 and a 52 week high of $69.85. The company has a market cap of $1.61 billion and a PE ratio of 141.91.

About Kinaxis

Kinaxis Inc is a provider of cloud-based subscription software for supply chain operations. The Company offers RapidResponse as a collection of cloud-based configurable applications. The Company’s RapidResponse product provides supply chain planning and analytics capabilities that create the foundation for managing multiple, interconnected supply chain management processes, including demand planning, supply planning, inventory management, order fulfillment and capacity planning.

Receive News & Stock Ratings for Kinaxis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis Inc and related stocks with our FREE daily email newsletter.